The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

ARS Pharmaceuticals, Inc. insider acquisitions

Company CIK 0001671858 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
SPRY · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate
30-day company acquisitions grouped by security, category, original code, and currency.
Type / codeReported securityTransactionsKnown purchase valueMissing amounts
Stock awardCode AStock Option (right to buy)Derivative · Currency not specified1Not applicable0

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Casale DonnCasale DonnChakma JustinChakma JustinDorsey BrianDorsey BrianCasale Donn · October 1, 2026 · Stock award · Stock Option (right to buy)Chakma Justin · November 12, 2025 · Exercise / conversion · Common StockDorsey Brian · November 13, 2025 · Exercise / conversion · Common StockNov 12, 2025Oct 1, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

3 dated transactions · 3 of 3 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 1, 2026ARS Pharmaceuticals, Inc.Stock Option (right to buy)Casale DonnStock award
Nov 12, 2025ARS Pharmaceuticals, Inc.Common StockChakma JustinExercise / conversion
Nov 13, 2025ARS Pharmaceuticals, Inc.Common StockDorsey BrianExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

SPRY · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Casale DonnPresident and CEO · Director
Stock awardStock Option (right to buy)Derivative security · Code A1,036,9230Value: 0Currency not specifiedView ↗
Trade:
Chakma JustinChief Business Officer
Exercise / conversionCommon StockNon-derivative security · Code M30,0000.84Value: 25,200Currency not specifiedView ↗
Trade:
Dorsey BrianChief Operating Officer
Exercise / conversionCommon StockNon-derivative security · Code M21,8280.64Value: 13,969.92Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →